Angiotensin receptor blockers and antiplatelet agents are associated with improved primary patency after arteriovenous hemodialysis access placement

Journal of Vascular Surgery

Volumn 54, Issue 6, 2011, Pages 1706-1712

  Jackson, Rubie Sue ^a,b   Sidawy, Anton N ^a,c   Amdur, Richard L ^a,b   Khetarpal, Akhil ^a   MacSata, Robyn A ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^c GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIANGINA PECTORIS AGENT; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FOLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; CONTINUOUS HEMODIALYSIS; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK REDUCTION; THROMBOSIS; TREATMENT FAILURE; TREATMENT OUTCOME; VASCULAR ACCESS; VASCULAR PATENCY; VEIN DILATATION;

ANGIOTENSIN RECEPTOR ANTAGONISTS; ARTERIOVENOUS SHUNT, SURGICAL; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 82955248058     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2011.06.028     Document Type: Article

References (29)

1. H.I. Feldman, S. Kobrin, and A. Wasserstein Hemodialysis vascular access morbidity J Am Soc Nephrol 7 1996 523 535
2. T.S. Huber, J.W. Carter, R.L. Carter, and J.M. Seeger Patency of autogenous and polytetrafluoroethylene upper extremity arteriovenous hemodialysis accesses: a systematic review J Vasc Surg 38 2003 1005 1011 (Pubitemid 37409635)
3. K.D. Gibson, D.L. Gillen, M.T. Caps, T.R. Kohler, D.J. Sherrard, and C.O. Stehman-Breen Vascular access survival and incidence of revisions: a comparison of prosthetic grafts, simple autogenous fistulas, and venous transposition fistulas from the United States Renal Data System Dialysis Morbidity and Mortality Study J Vasc Surg 34 2001 694 700 (Pubitemid 33664921)
4. R. Saran, D.M. Dykstra, R.A. Wolfe, B. Gillespie, P.J. Held, and E.W. Young Association between vascular access failure and the use of specific drugs: the Dialysis Outcomes and Practice Patterns Study (DOPPS) Am J Kidney Dis 40 2002 1255 1263 (Pubitemid 35403138)
5. R. Gradzki, R.K. Dhingra, F.K. Port, E. Roys, W.F. Weltzel, and J.M. Messana Use of ACE inhibitors is associated with prolonged survival of arteriovenous grafts Am J Kidney Dis 28 2001 1240 1244 (Pubitemid 34193109)
6. A. Sajgure, A. Choudhury, Z. Ahmed, and D. Choudhury Angiotensin converting enzyme inhibitors maintain polytetrafluroethylene graft patency Nephrol Dial Transplant 22 2007 1390 1398 (Pubitemid 47072228)
7. C.J. Diskin, T.J. Stokes, S.G. Thomas, W. Ravis, S. Lock, and J. Thomas An analysis of the effect of routine medications on hemodialysis vascular access survival Nephron 78 1998 365 368 (Pubitemid 28102630)
8. A. Ghorbani, M. Aalamshah, H. Shahbazian, A. Ehsanpour, and A. Aref Randomized controlled trial of clopidogrel to prevent primary arteriovenous fistula failure in hemodialysis patients Indian J Nephrol 19 2009 57 61
9. J.S. Kaufman, T.Z. O'Connor, J.H. Zhang, R.E. Cronin, L.D. Fiore, and M.B. Ganz Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis J Am Soc Nephrol 14 2003 2313 2321 (Pubitemid 37052378)
10. R. Sreedhara, J. Himmelfarb, M.J. Lazarus, and R.M. Hakim Anti-platelet therapy in graft thrombosis: results of a prospective, randomized, double-blind study Kidney Int 45 1994 1477 1483 (Pubitemid 24135036)
11. A.S. Yevzlin, E.L. Conley, R.J. Sanchez, H.N. Young, and B.N. Becker Vascular access outcomes and medication use: a USRDS study Semin Dial 19 2006 535 539 (Pubitemid 44736562)
12. J.M. Garrancho, J. Kirchgessner, M. Arranz, G. Klinkner, R. Rentero, and J.A. Ayala Haemoglobin level and vascular access survival in haemodialysis patients Nephrol Dial Transplant 20 2005 2453 2457 (Pubitemid 41548871)
13. J.Y. Moon, K.H. Jeong, S.S. Paik, J.J. Han, S.H. Lee, and T.W. Lee Arteriovenous fistula patency associated with angiotensin-converting enzyme I/D polymorphism and ACE inhibition or AT1 receptor blockade Nephron Clin Pract 111 2009 c110 c116
14. A.N. Sidawy, R. Gray, A. Besarab, M. Henry, E. Ascher, and M. Silva Jr Recommended standards for reports dealing with arteriovenous hemodialysis accesses J Vasc Surg 35 2002 603 610 (Pubitemid 44718614)
15. A.N. Sidawy, L.M. Spergel, A. Besarab, M. Allon, W.C. Jennings, and F.T. Padberg Jr The Society for Vascular Surgery: clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access J Vasc Surg 48 5 Suppl 2008 2S 25S
16. B.G. Katzung, S.M. Masters, and A.J. Trevor Basic and Clinical Pharcology: 11e 2009 McGraw-Hill
17. J. Baan Jr, P.C. Chang, P. Vermeij, M. Pfaffendorf, and P.A. van Zwieten Venoconstriction by angiotensin II in the human forearm is inhibited by losartan but not by nicardipine J Cardiovasc Pharmacol 31 1998 50 55 (Pubitemid 28027898)
18. P. Li, M. Fukuhara, D.I. Diz, C.M. Ferrario, and K.B. Brosnihan Novel angiotensin II AT(1) receptor antagonists irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation J Pharmacol Exp Ther 292 2000 238 246 (Pubitemid 30026376)
19. L. Kalinowski, T. Matys, E. Chabielska, W. Buczko, and T. Malinski Angiotensin II AT1 receptor antagonists inhibit platelet adhesion and aggregation by nitric oxide release Hypertension 40 2002 521 527
20. M. Katoh, K. Egashira, T. Mitsui, S. Chishima, A. Takeshita, and H. Narita Angiotensin-converting enzyme inhibitor prevents plasminogen activator inhibitor-1 expression in a rat model with cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis J Mol Cell Cardiol 32 2000 73 83 (Pubitemid 30064306)
21. H. Nishimura, H. Tsuji, H. Masuda, K. Nakagawa, Y. Nakahara, and H. Kitamura Angiotensin II increases plasminogen activator inhibitor-1 and tissue factor mRNA expression without changing that of tissue type plasminogen activator or tissue factor pathway inhibitor in cultured rat aortic endothelial cells Thromb Haemost 77 1997 1189 1195 (Pubitemid 27311993)
22. T. Yamada, T. Kondo, Y. Numaguchi, M. Tsuzuki, T. Matsubara, and I. Manabe Angiotensin II receptor blocker inhibits neointimal hyperplasia through regulation of smooth muscle-like progenitor cells Arterioscler Thromb Vasc Biol 27 2007 2363 2369 (Pubitemid 350203951)
23. M.K. O'Donohoe, L.B. Schwartz, Z.S. Radic, E.M. Mikat, R.L. McCann, and P.O. Hagen Chronic ACE inhibition reduces intimal hyperplasia in experimental vein grafts Ann Surg 214 1991 727 732
24. S. Yagi, T. Morita, and S. Katayama Combined treatment with an AT1 receptor blocker and angiotensin converting enzyme inhibitor has an additive effect on inhibiting neointima formation via improvement of nitric oxide production and suppression of oxidative stress Hypertens Res 27 2004 129 135 (Pubitemid 38325183)
25. M. Chen, T. Ichiki, H. Ohtsubo, I. Imayama, K. Inanaga, and R. Miyazaki Inhibition of balloon injury-induced neointimal formation by olmesartan and pravastatin in rats with insulin resistance Hypertens Res 30 2007 971 978 (Pubitemid 350120976)
26. O. Yoshida, H. Hirayama, M. Nanasato, T. Watanabe, and T. Murohara The angiotensin II receptor blocker candesartan cilexetil reduces neointima proliferation after coronary stent implantation: a prospective randomized study under intravascular ultrasound guidance Am Heart J 149 2005 e2
27. M. Yoshikawa, K. Nakamura, S. Nagase, S. Sakuragi, K.F. Kusano, and H. Matsubara Effects of combined treatment with angiotensin II type 1 receptor blocker and statin on stent restenosis J Cardiovasc Pharmacol 53 2009 179 186
28. K. Bian, M.F. Doursout, and F. Murad Vascular system: role of nitric oxide in cardiovascular diseases J Clin Hypertens (Greenwich) 10 2008 304 310
29. B.F. Becker, B. Heindl, C. Kupatt, and S. Zahler Endothelial function and hemostasis Z Kardiol 89 2000 160 167 (Pubitemid 30210333)